Boehringer Ingelheim announces IBD research collaborations 10 November 2015 | By Victoria White The collaborations aim to identify and validate potential new therapeutic targets as well as identify biomarkers...
Pharnext’s PXT-864 shows promise in Parkinson’s disease 10 November 2015 | By Victoria White In preclinical studies, researchers showed that PXT-864, a combination of baclofen and acamprosate, improved multiple endpoints associated with the development and progression of Parkinson's disease...
Sanofi Pasteur reveals universal flu vaccine research 10 November 2015 | By Victoria White Sanofi Pasteur's experimental vaccine is a novel synthetic vaccine generated from key genetic sequences of many flu viruses...
Scientists discover genetic cause and mechanism of noise-induced hearing loss 6 November 2015 | By Victoria White The absence of pejvakin appears to be responsible for noise-induced hearing loss, one of the most common causes of deafness...
Global and USA Biosimilar Market: Updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim 6 November 2015 | By SMi Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...
Possible solution for Alzheimer’s immunotherapy side effect 6 November 2015 | By Victoria White Scientists have discovered that small changes in anti-amyloid antibodies preserves the immunotherapeutic activity without the inflammatory side effects...
Scientists identify compound that could reverse cataracts 6 November 2015 | By Victoria White Eye drops made with the compound partially restored transparency to mouse lenses affected by cataracts...
National MS Society invests $21m in 78 new research projects 6 November 2015 | By This financial commitment is part of a projected investment of over $53 million in 2015 alone to support more than 380 new and ongoing studies around the world.
Scientists investigate the function of protein MHC1 6 November 2015 | By Victoria White The scientists have been awarded £700,000 to work in collaboration with Unilever scientists to explore ways to minimise allergic reactions to additives in healthcare products...
New collaboration to research Probody-enabled CAR-NK cell therapies 6 November 2015 | By Victoria White ProCAR-NK cell therapies will be created against targets for which safety and toxicity have traditionally been limiting factors for CAR cell therapies...
Researchers try to turn acid-loving S. islandicus into a drug-carrier 5 November 2015 | By Victoria White Researchers have shown that the microbe S. islandicus, normally found in hot and acidic volcanic springs, is capable of delivering drugs to the human body...
Researchers harness brain’s immune system to clear amyloid plaques 5 November 2015 | By Victoria White The investigations were triggered when scientists observed that amyloid plaques were being cleared in mice with chronic brain inflammation...
MabVax completes manufacturing of HuMab 5B1 in preparation for Phase I trials 4 November 2015 | By Victoria White In preclinical research, HuMab 5B1 has shown potent cancer cell killing capacity and efficacy...
Eisai and IPC enter oncology R&D collaboration 4 November 2015 | By Victoria White IPC will perform chemo-informatic virtual screening of a pre-selected Eisai chemical library, to identify new protein-protein inhibitors for further biological evaluation...
Scientists develop 3-D printing method for embryonic stem cells 4 November 2015 | By Victoria White Scientists have developed a 3-D printing method capable of producing highly uniform embryoid body that could eventually be used for tissue regeneration...
